187 related articles for article (PubMed ID: 22658385)
1. Dose matters: the importance of appropriate dosing: a case report on sunitinib treatment in a patient with metastatic renal cell carcinoma.
Bojic M; Schmidinger M
Clin Genitourin Cancer; 2012 Dec; 10(4):277-9. PubMed ID: 22658385
[No Abstract] [Full Text] [Related]
2. Long-term response with sunitinib for metastatic renal cell carcinoma.
Ronnen EA; Kondagunta GV; Ginsberg MS; Russo P; Motzer RJ
Urology; 2006 Sep; 68(3):672.e19-20. PubMed ID: 16979716
[TBL] [Abstract][Full Text] [Related]
3. Improvement of psoriasis during sunitinib therapy for renal cell carcinoma.
Narayanan S; Callis-Duffin K; Batten J; Agarwal N
Am J Med Sci; 2010 Jun; 339(6):580-1. PubMed ID: 20421784
[TBL] [Abstract][Full Text] [Related]
4. Intermittent sunitinib for metastatic renal cell carcinoma.
Venkatesan P
Lancet Oncol; 2017 Mar; 18(3):e139. PubMed ID: 28163004
[No Abstract] [Full Text] [Related]
5. Sunitinib for metastatic renal cell carcinoma.
Mukherji D; Larkin J; Pickering L
Future Oncol; 2010 Sep; 6(9):1377-85. PubMed ID: 20919823
[TBL] [Abstract][Full Text] [Related]
6. [News on ASCO 2007. Sunitinib in the treatment of metastatic renal carcinoma and gastrointestinal stromal tumors].
Mansueto G; Longo F
Tumori; 2007; 93(5):Suppl 1-16. PubMed ID: 18038894
[No Abstract] [Full Text] [Related]
7. Metastatic mucinous tubular and spindle cell carcinoma of the kidney responding to sunitinib.
Larkin J; Fisher R; Pickering L; Thway K; Livni N; Fisher C; Gore M
J Clin Oncol; 2010 Oct; 28(28):e539-40. PubMed ID: 20679595
[No Abstract] [Full Text] [Related]
8. Phase III study of sunitinib malate (SU11248) versus interferon-alpha as first-line treatment in patients with metastatic renal cell carcinoma.
Reddy K
Clin Genitourin Cancer; 2006 Jun; 5(1):23-5. PubMed ID: 16859575
[No Abstract] [Full Text] [Related]
9. Intermittent treatment with sunitinib may achieve complete response in metastatic renal cell carcinoma.
Aksu G; Ensaroglu F; Dolasik I; Temiz S; Halis H; Sener SY; Kaya A; Uygun K
J BUON; 2010; 15(4):798-9. PubMed ID: 21229650
[No Abstract] [Full Text] [Related]
10. Successful sunitinib treatment of metastatic renal cell carcinoma in a patient with end stage renal disease on hemodialysis.
Park CY
Anticancer Drugs; 2009 Oct; 20(9):848-9. PubMed ID: 19644356
[TBL] [Abstract][Full Text] [Related]
11. Multifocal brain metastases in clear cell renal cell carcinoma with complete response to sunitinib.
Zeng H; Li X; Yao J; Zhu Y; Liu J; Yang Y; Qiang W
Urol Int; 2009; 83(4):482-5. PubMed ID: 19996660
[TBL] [Abstract][Full Text] [Related]
12. Dramatic effect of sunitinib with rapid but transient improvement for psoriasis in a patient with metastatic renal carcinoma.
Kato Y; Yamamoto T
J Dermatol; 2013 Dec; 40(12):1069-70. PubMed ID: 24330182
[No Abstract] [Full Text] [Related]
13. Prostatic metastasis of renal cell carcinoma successfully treated with sunitinib.
Fokt RM; Templeton A; Gillessen S; Ohlschlegel C; Schmid HP
Urol Int; 2009; 83(1):122-4. PubMed ID: 19641373
[TBL] [Abstract][Full Text] [Related]
14. Tolerance of sunitinib in dialyzed patients with metastatic renal cell carcinoma.
Vickers MM; Heng DY; Hemmelgarn B; Eigl BJ
Clin Genitourin Cancer; 2009 Oct; 7(3):E104-6. PubMed ID: 19815480
[TBL] [Abstract][Full Text] [Related]
15. Effect of sunitinib on renal cell carcinoma cutaneous metastasis.
Liu SW; Guitart JG; Kuzel TM; Gandhi M; Lacouture M
Int J Dermatol; 2009 Nov; 48(11):1269-70. PubMed ID: 20064194
[No Abstract] [Full Text] [Related]
16. Improvement of actinic keratosis associated with sunitinib therapy for metastatic renal cell carcinoma.
Mir-Bonafé JM; Cañueto J; Bravo J; de Unamuno P
Int J Dermatol; 2013 Nov; 52(11):1445-7. PubMed ID: 23432117
[No Abstract] [Full Text] [Related]
17. Temsirolimus for advanced renal-cell carcinoma.
Fazio N; Dettori M; Lorizzo K
N Engl J Med; 2007 Sep; 357(10):1050; author reply 1050-1. PubMed ID: 17804854
[No Abstract] [Full Text] [Related]
18. Consolidative renal cell carcinoma metastatectomy for partial response after multitargeted tyrosine kinase inhibitor therapy.
Neill MG; Wei AC; Jewett MA
Urology; 2007 Jul; 70(1):178.e9-11. PubMed ID: 17656238
[TBL] [Abstract][Full Text] [Related]
19. [Use of sunitinib in metastatic renal cell carcinoma patients with poor prognosis].
Timofeev IV; Demidov LV; Petenko NN
Vopr Onkol; 2011; 57(1):50-4. PubMed ID: 21598708
[TBL] [Abstract][Full Text] [Related]
20. Complete response to sunitinib in a patient with relapsed irresectable renal cell carcinoma.
Vaz MA; Pachón V; Grande E; Ferreiro R; Carrato A
Anticancer Drugs; 2011 Sep; 22(8):817-21. PubMed ID: 21566523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
